CervoMed Inc. — Director's Dealing 2021

May 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Diffusion Pharmaceuticals Inc. (DFFN)
CIK: 0001053691
Period of Report: 2021-05-13

Reporting Person: Hollingsworth Jane H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-13	Common Stock	P	32786	$0.61	Acquired	32786	Direct

Footnotes

F1: The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6097 to $0.6141, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.